Informative Exhibition for Deprescribing Benzodiazepines
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Informative Session.
- Who it may be relevant to
- Registry conditions: Benzodiazepine-Related Disorders. Basic parameters: 18 years — 99 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Spain
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Impact of an Interactive and Informative Exhibition on Benzodiazepine Use on Deprescription.
Overview
The goal of this trial is to determine if an interactive and informative exhibition in the waiting room of a Primary Care Clinic can reduce the use of benzodiazepines in adults. The main question it aims to answer is: • Does an interactive and informative exhibition reduce the number of participants using benzodiazepines? Researchers will compare benzodiazepine consumption before and after the interactive and informative exhibition implementation at study center. Participants will receive an informative and interactive exhibition on the risks of chronic benzodiazepine use. A single informative session on the same topic will be conducted for health professionals.
Interventions
- Other Informative Session
The intervention consists of implementing an interactive exhibition on the risks of chronic benzodiazepine treatment in the waiting room of a primary care center. Additionally, the health professionals at the center will receive a single informative session on the same topic.
Primary outcome measures
- Chronic treatment with benzodiazepines [Time frame: 1 year]
Eligibility criteria
Inclusion criteria
- Men and women between 18 and 99 years of age.
- Attended at the Baix-a-Mar Primary Care Center during the study period.
Exclusion criteria
- Severe mental health disease
- Displaced patients or those who do not have an assigned doctor at the center.
- Participation in another study involving an experimental intervention during the period of the present study that affects benzodiazepine prescription.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Other
Study locations
Spain · 1 center
- Centro de Salud Vilanova i la Geltrú 3 Baix A Mar — Vilanova i la Geltrú
Identifiers
NCT: NCT06467019 · CSAPG-59